“AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability” (2026) Explore Medical Science and Global Health, 3, pp. 38–47. doi:10.70267/emsgh.v3.3847.